GSA Capital Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.4M | Buy |
24,858
+13,154
| +112% | +$767K | 0.09% | 314 |
|
|
2025
Q4 | $696K | Sell |
11,704
-7,684
| -40% | -$418K | 0.06% | 594 |
|
|
2025
Q3 | $1.05M | Buy |
19,388
+2,156
| +13% | +$123K | 0.09% | 368 |
|
|
2025
Q2 | $947K | Buy |
17,232
+2,421
| +16% | +$143K | 0.07% | 491 |
|
|
2025
Q1 | $1.05M | Buy |
14,811
+7,393
| +100% | +$497K | 0.09% | 321 |
|
|
2024
Q4 | $488K | Buy |
+7,418
| New | +$497K | 0.04% | 909 |
|
|
2024
Q2 | – | Sell |
-7,035
| Closed | -$614K | – | 1637 |
|
|
2024
Q1 | $614K | Buy |
+7,035
| New | +$630K | 0.05% | 761 |
|
|
2023
Q4 | – | Sell |
-6,373
| Closed | -$564K | – | 1520 |
|
|
2023
Q3 | $564K | Sell |
6,373
-638
| -9% | -$56.8K | 0.05% | 717 |
|
|
2023
Q2 | $608K | Buy |
7,011
+4,376
| +166% | +$412K | 0.06% | 621 |
|
|
2023
Q1 | $256K | Sell |
2,635
-1,908
| -42% | -$198K | 0.03% | 1122 |
|
|
2022
Q4 | $470K | Buy |
+4,543
| New | +$426K | 0.06% | 641 |
|
|
2022
Q3 | – | Sell |
-19,438
| Closed | -$1.61M | – | 1526 |
|
|
2022
Q2 | $1.61M | Sell |
19,438
-2,352
| -11% | -$187K | 0.24% | 34 |
|
|
2022
Q1 | $1.68M | Buy |
+21,790
| New | +$1.82M | 0.23% | 53 |
|
|
2021
Q4 | – | Sell |
-10,780
| Closed | -$833K | – | 1421 |
|
|
2021
Q3 | $833K | Buy |
10,780
+8,270
| +329% | +$653K | 0.08% | 399 |
|
|
2021
Q2 | $209K | Buy |
+2,510
| New | +$199K | 0.02% | 1165 |
|
|
2018
Q4 | – | Sell |
-2,288
| Closed | -$222K | – | 1364 |
|
|
2018
Q3 | $222K | Sell |
2,288
-962
| -30% | -$96K | 0.01% | 1449 |
|
|
2018
Q2 | $306K | Sell |
3,250
-491
| -13% | -$43K | 0.02% | 1379 |
|
|
2018
Q1 | $303K | Buy |
+3,741
| New | +$321K | 0.02% | 1304 |
|
|
2017
Q2 | – | Sell |
-7,907
| Closed | -$694K | – | 1679 |
|
|
2017
Q1 | $694K | Sell |
7,907
-8,296
| -51% | -$738K | 0.04% | 884 |
|
|
2016
Q4 | $1.34M | Sell |
16,203
-9,014
| -36% | -$775K | 0.08% | 386 |
|
|
2016
Q3 | $2.33M | Buy |
25,217
+18,192
| +259% | +$1.71M | 0.13% | 186 |
|
|
2016
Q2 | $547K | Buy |
+7,025
| New | +$597K | 0.03% | 1015 |
|
|
2016
Q1 | – | Sell |
-18,498
| Closed | -$1.94M | – | 1676 |
|
|
2015
Q4 | $1.94M | Sell |
18,498
-73,834
| -80% | -$7.71M | 0.09% | 271 |
|
|
2015
Q3 | $9.72M | Buy |
92,332
+66,366
| +256% | +$8.86M | 0.48% | 11 |
|
|
2015
Q2 | $3.55M | Buy |
25,966
+8,078
| +45% | +$1M | 0.14% | 117 |
|
|
2015
Q1 | $2.23M | Buy |
+17,888
| New | +$1.9M | 0.09% | 287 |
|
|
2014
Q2 | – | Sell |
-37,363
| Closed | -$2.55M | – | 1807 |
|
|
2014
Q1 | $2.55M | Buy |
37,363
+29,754
| +391% | +$2.19M | 0.18% | 105 |
|
|
2013
Q4 | $535K | Buy |
+7,609
| New | +$517K | 0.04% | 791 |
|
|
2013
Q3 | – | Sell |
-14,513
| Closed | -$809K | – | 1561 |
|
|
2013
Q2 | $809K | Buy |
+14,513
| New | +$904K | 0.1% | 292 |
|
Other funds holding BMRN
VCM
VPM
